Immunocore Holdings plc

Immunocore Holdings plc (ticker: IMCR) is an NASDAQ-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of IMCR's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. IMCR reported $106.68M in revenue and $12.97M for the period ending 2026-03-31, with operating cash flow of -$13.78M. Cash and equivalents stood at $452.68M (down 5.1% year-over-year). Total assets of $1.07B exceed total liabilities of $678.42M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

IMCR Risk Flags

Consolidated view of every risk_flag row IMCRhas surfaced across DredgeCap's extractor pipeline (auditor changes, late filings, delistings, going-concern, dilution, etc.). Each row carries a verbatim source_excerpt and links to the source SEC filing on EDGAR.

Category	Severity	Source	Excerpt	EDGAR
Auditor Change	low	10-K · Feb 25, 2026	PCAOB-tagged auditor in 10-K filed 2026-02-25 (accession 0001671927-26-000005) was 'Deloitte LLP' (PCAOB Firm ID: 1147). Prior 10-K filed 2025-02-26 (accession 0001671927-25-000006) was 'KPMG LLP' (PCAOB Firm ID: 1118).	view ↗

Related on IMCR

Auditor & opinion →

Source for auditor_change + going-concern flags.

Share-count dilution →

Source for dilution + convertible-debt flags.

Risk-flag rows are produced by DredgeCap's extractor pipeline (lib/extract-auditor-changes, extract-late-filings, etc.). Each row carries a verbatim source_excerpt from the underlying SEC filing — no AI-generated language. Refresh runs daily. Not financial advice.